Therefore, we assumed that the decreased expression of miR-26b resulted in the high level of EphA2. Here we detected the expression of EphA2 in normal brain, glioma samples of different grades, and three glioma cell lines. The gene discussed is EPHA2; the disease is central nervous system cancer.